Novo Nordisk hit with FDA warning letter over acquired Catalent factory
Novo Nordisk hit with FDA warning letter over acquired Catalent factory
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.
Novo Nordisk hit with FDA warning letter over acquired Catalent factory
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.